AOD-9604 is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
AOD-9604 is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Resolve the exact identity of AOD-9604 through Read the FDA source from U.S. Food and Drug Administration. Then search Lists of authorized medicinal products from Swissmedic for the destination product record and Guideline on medicines and the Internet from Swissmedic for the seller, establishment, or supply route in Switzerland. A match in one record does not replace the other two checks.
No. A page using the name AOD-9604, local currency, a domestic delivery claim, or a familiar package image is only a lead. AOD-9604 reached controlled human studies, but the largest oral obesity trial did not show a statistically significant weight-loss difference and the sponsor terminated development for obesity. FDA states that neither AOD-9604 free base nor acetate is a component of an approved drug. Current seller-labelled 5 mg research vials do not inherit the identity, route, formulation, manufacturing record, or monitoring of the historical trial products. For Switzerland, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
AOD-9604 is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Primary identity source: Read the FDA source / U.S. Food and Drug Administration ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Read the FDA source is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Read the FDA source ↗Lists of authorized medicinal products is maintained by Swissmedic. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Lists of authorized medicinal products ↗Guideline on medicines and the Internet is maintained by Swissmedic. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Guideline on medicines and the Internet ↗Swiss medicine authorization and online dispensing are different checks. Swissmedic publishes current authorized-product information, while mail-order dispensing involves legal conditions and cantonal licensing that a foreign seller claim cannot establish.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use Swissmedic's current lists and product-information platform to match the exact medicine, pack, authorization holder, and status instead of extrapolating from an active-substance name.
Read Swissmedic's internet-medicine guidance and verify the relevant cantonal mail-order licence. A Swiss-looking domain or address is not evidence of that permission.
Import conditions, a customs outcome, and local licensed dispensing are different routes. Record which one an offer claims before comparing price or availability.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.